Royce & Associates’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.6M Buy
780,938
+223,000
+40% +$4.28M 0.15% 224
2026
Q1
$9.83M Buy
557,938
+35,478
+7% +$713K 0.1% 331
2025
Q4
$10.3M Buy
522,460
+8,400
+2% +$151K 0.1% 294
2025
Q3
$8.97M Buy
514,060
+97,000
+23% +$1.44M 0.09% 330
2025
Q2
$5.84M Sell
417,060
-257,950
-38% -$4.15M 0.06% 427
2025
Q1
$12.6M Sell
675,010
-106,670
-14% -$1.59M 0.14% 230
2024
Q4
$8.79M Buy
781,680
+461,680
+144% +$5.4M 0.08% 358
2024
Q3
$3.78M Buy
+320,000
New +$3.03M 0.03% 525

Other funds holding ALHC

Royce & Associates's ALHC Position: Q2 2026 in Review

Royce & Associates increased its Alignment Healthcare (ALHC) stake by 40% in Q2 2026, buying an estimated $4.28M and bringing the position to 780,938 shares worth $18.6M. The position accounts for 0.15% of the portfolio, ranked #224.

Royce & Associates first reported a position in ALHC in Q3 2024 and has held it in 8 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Royce & Associates held 780,938 shares of Alignment Healthcare worth $18.6M as of Q2 2026.
  • Royce & Associates bought 223,000 Alignment Healthcare shares in Q2 2026, an estimated $4.28M.
  • Alignment Healthcare made up 0.15% of Royce & Associates's portfolio in Q2 2026, its #224 holding.
  • Royce & Associates first reported a position in Alignment Healthcare in Q3 2024 and has held it in 8 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.